Oncoclinicas do Brasil Total Liabilities
Oncoclinicas do Brasil total liabilities. Based on the latest financial reports, Oncoclinicas do Brasil (ONCO3) has total liabilities worth R$7.02 Billion BRL (≈ $1.38 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of Oncoclinicas do Brasil to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Oncoclinicas do Brasil (2013–2024)
Total liabilities of Oncoclinicas do Brasil from 2013 to 2024. This chart illustrates how Oncoclinicas do Brasil's total liabilities have evolved over time, based on quarterly financial data. Check ONCO3 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Oncoclinicas do Brasil Competitors by Total Liabilities
The table below lists competitors of Oncoclinicas do Brasil ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Duluth Holdings Inc
NASDAQ:DLTH
|
USA | $236.49 Million |
|
Answear.com S.A.
WAR:ANR
|
Poland | zł628.64 Million |
|
Caisse Regionale De Credit Agricole Mutuel Sud Rhone Alpes
PA:CRSU
|
France | €24.15 Billion |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd B
SHG:900912
|
China | $30.68 Billion |
|
SENFONG
KLSE:5308
|
Malaysia | RM230.75 Million |
|
Ugro Capital Limited
NSE:UGROCAP
|
India | Rs111.69 Billion |
|
Geumhwa Plant Service & Construction Co. Ltd
KQ:036190
|
Korea | ₩85.49 Billion |
|
Korvest Ltd
AU:KOV
|
Australia | AU$30.87 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Oncoclinicas do Brasil's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Oncoclinicas do Brasil total assets.
Liquidity & Leverage Metrics
Oncoclinicas do Brasil Total Liabilities Ratios Explained
Oncoclinicas do Brasil total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.06 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 7.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oncoclinicas do Brasil's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oncoclinicas do Brasil (2013–2024)
The table below shows the annual total liabilities of Oncoclinicas do Brasil from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | R$7.82 Billion ≈ $1.53 Billion |
+20.27% |
| 2023-12-31 | R$6.50 Billion ≈ $1.28 Billion |
+16.37% |
| 2022-12-31 | R$5.59 Billion ≈ $1.10 Billion |
+49.90% |
| 2021-12-31 | R$3.73 Billion ≈ $731.40 Million |
+37.43% |
| 2020-12-31 | R$2.71 Billion ≈ $532.20 Million |
+86.55% |
| 2019-12-31 | R$1.45 Billion ≈ $285.28 Million |
+65.56% |
| 2018-12-31 | R$878.19 Million ≈ $172.32 Million |
+58.52% |
| 2017-12-31 | R$553.99 Million ≈ $108.70 Million |
+47.92% |
| 2016-12-31 | R$374.51 Million ≈ $73.49 Million |
+14.68% |
| 2015-12-31 | R$326.58 Million ≈ $64.08 Million |
-3.43% |
| 2014-12-31 | R$338.17 Million ≈ $66.35 Million |
+24.20% |
| 2013-12-31 | R$272.27 Million ≈ $53.43 Million |
-- |
About Oncoclinicas do Brasil
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more